This study will help us in understanding how this disease progresses and why some became sicker. This study may also help in the development of novel therapy.
Not Applicable
Completed
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2020/12/029983
- Lead Sponsor
- ational Institute of malaria Research New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
Adult of both sexes sufferings or recovered from covid 19 pneumonia will be recruited
Exclusion Criteria
Patients with pre-existing respiratory diseases i.e. active pulmonary tuberculosis, bronchial asthma, and chronic obstructive pulmonary disease will be excluded from the study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method â?¢Differential protease expression in patients with SARS-CoV-2 infection who required supplemental oxygen/invasive/non-invasive ventilation vs healthy individuals and mild COVID patients who didnâ??t require supplemental oxygen. <br/ ><br> <br/ ><br>â?¢Identification of unusual proteases and their inhibitors. <br/ ><br> <br/ ><br>â?¢Identification and database preparation of target proteins involved in the pathogenesis of SARS-CoV-2 disease. <br/ ><br> <br/ ><br>Timepoint: At base line
- Secondary Outcome Measures
Name Time Method oneTimepoint: None